Process Development Improvements Post-Pandemic

Published on: 

What can the biopharma industry learn from its rapid response to the COVID-19 pandemic?

In this expert interview with BioPharm International, James Blackwell, president of The Windshire Group, LLC, explains key actions the biopharma can learn from its response to the COVID-19 pandemic that can be applied to improve process development for non-pandemic development programs.

Related Content:

Process DevelopmentDevelopmentCOVID-19 Update
Novartis and Monte Rosa Therapeutics Form $2.1 Billion Global License Agreement for MGD-based Therapeutics
BioDuro-Sundia Opens New Kilogram Laboratory at Shanghai Site
Merck Acquires Modifi Biosciences